• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Laryngoscope . Quantification of Aerosol Concentrations During Endonasal Instrumentation in the Clinic Setting

tetano

Editor, Senior Moderator
Laryngoscope


. 2020 Oct 5.
doi: 10.1002/lary.29122. Online ahead of print.
Quantification of Aerosol Concentrations During Endonasal Instrumentation in the Clinic Setting


Alexander T Murr[SUP] 1 [/SUP], Nicholas R Lenze[SUP] 1 [/SUP], Mark W Gelpi[SUP] 1 [/SUP], William C Brown[SUP] 1 [/SUP], Charles S Ebert Jr[SUP] 1 [/SUP], Brent A Senior[SUP] 1 [/SUP], Brian D Thorp[SUP] 1 [/SUP], Adam J Kimple[SUP] 1 [/SUP], Adam M Zanation[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: Recent anecdotal reports and cadaveric simulations have described aerosol generation during endonasal instrumentation, highlighting a possible risk for transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during endoscopic endonasal instrumentation. This study aims to provide a greater understanding of particle generation and exposure risk during endoscopic endonasal instrumentation.
Study design: Prospective quantification of aerosol generation during office-based nasal endoscopy procedures.
Methods: Using an optical particle sizer, airborne particles concentrations 0.3 to 10 microns in diameter, were measured during 30 nasal endoscopies in the clinic setting. Measurements were taken at time points throughout diagnostic and debridement endoscopies and compared to preprocedure and empty room particle concentrations.
Results: No significant change in airborne particle concentrations was measured during diagnostic nasal endoscopies in patients without the need for debridement. However, significant increases in mean particle concentration compared to preprocedure levels were measured during cold instrumentation at 2,462 particles/foot[SUP]3[/SUP] (95% CI 837 to 4,088; P = .005) and during suction use at 2,973 particle/foot[SUP]3[/SUP] (95% CI 1,419 to 4,529; P = .001). In total, 99.2% of all measured particles were ≤1 μm in diameter.
Conclusion: When measured with an optical particle sizer, diagnostic nasal endoscopy with a rigid endoscope is not associated with increased particle aerosolization in patient for whom sinonasal debridement is not needed. In patients needing sinonasal debridement, endonasal cold and suction instrumentation were associated with increased particle aerosolization, with a trend observed during endoscope use prior to tissue manipulation. Endonasal debridement may potentially pose a higher risk for aerosolization and SARS-CoV-2 transmission. Appropriate personal protective equipment use and patient screening are recommended for all office-based endonasal procedures.
Level of evidence: 3 Laryngoscope, 2020.

Keywords: COVID-19; aerosol-generating procedures; droplet quantification; nasal endoscopy; optical particle sizer.
 
Back
Top Bottom